��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
創業家(8477)
月營收
季盈餘
2025/03/01
13.30元 (創業家股價)
2025/03/01
-53.12%
(年增率)
46百萬元 (營收)
創業家(8477) 年度營收走勢圖
創業家(8477)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
45,511
-1.32%
97,082
-53.12%
139,644
-51.38%
114/02
46,120
-3.94%
78,014
-40.88%
94,133
-50.49%
114/01
48,013
-9.89%
112,111
-57.17%
48,013
-57.17%
113/12
53,282
-16.79%
105,479
-49.49%
877,558
-33.46%
113/11
64,035
2.26%
127,406
-49.74%
824,276
-32.07%
113/10
62,618
21.35%
105,102
-40.42%
760,241
-30.00%
113/09
51,602
-15.30%
115,023
-55.14%
697,623
-28.88%
113/08
60,922
-1.34%
96,855
-37.10%
646,021
-25.39%
113/07
61,752
0.25%
92,737
-33.41%
585,099
-23.92%
113/06
61,601
-30.68%
100,430
-38.66%
523,347
-22.62%
113/05
88,871
3.74%
106,321
-16.41%
461,746
-19.82%
113/04
85,668
-11.76%
101,623
-15.70%
372,875
-20.59%
113/03
97,082
24.44%
125,571
-22.69%
287,207
-21.94%
113/02
78,014
-30.41%
116,219
-32.87%
190,125
-21.55%
113/01
112,111
6.29%
126,144
-11.12%
112,111
-11.12%
112/12
105,479
-17.21%
163,219
-35.38%
1,318,908
-43.95%
112/11
127,406
21.22%
176,770
-27.93%
1,213,430
-44.58%
112/10
105,102
-8.63%
151,954
-30.83%
1,086,024
-46.05%
112/09
115,023
18.76%
164,815
-30.21%
980,922
-47.29%
112/08
96,855
4.44%
186,810
-48.15%
865,899
-48.95%
112/07
92,737
-7.66%
180,087
-48.50%
769,044
-49.05%
112/06
100,430
-5.54%
212,589
-52.76%
676,307
-49.12%
112/05
106,321
4.62%
228,294
-53.43%
575,877
-48.43%
112/04
101,623
-19.07%
200,460
-49.31%
469,555
-47.14%
112/03
125,571
8.05%
221,737
-43.37%
367,933
-46.51%
112/02
116,219
-7.87%
200,642
-42.08%
242,362
-48.01%
112/01
126,144
-22.71%
265,526
-52.49%
126,144
-52.49%
111/12
163,219
-7.67%
247,220
-33.98%
2,352,902
-35.92%
111/11
176,770
16.33%
279,546
-36.77%
2,189,683
-36.06%
111/10
151,954
-7.80%
224,825
-32.41%
2,012,913
-35.99%
111/09
164,815
-11.77%
250,013
-34.08%
1,860,958
-36.27%
111/08
186,810
3.73%
280,122
-33.31%
1,696,143
-36.48%
111/07
180,087
-15.29%
339,996
-47.03%
1,509,334
-36.85%
111/06
212,589
-6.88%
469,734
-54.74%
1,329,246
-35.16%
111/05
228,294
13.89%
396,123
-42.37%
1,116,657
-29.34%
111/04
200,460
-9.60%
262,801
-23.72%
888,364
-24.97%
111/03
221,737
10.51%
288,659
-23.18%
687,904
-25.33%
111/02
200,642
-24.44%
466,167
111/01
265,526
7.40%
265,526
110/12
247,220
-11.56%
3,671,667
110/11
279,546
24.34%
3,424,448
110/10
224,825
-10.07%
3,144,902
110/09
250,013
-10.75%
2,920,078
110/08
280,122
-17.61%
2,670,065
110/07
339,996
-27.62%
2,389,943
110/06
469,734
18.58%
2,049,947
110/05
396,123
50.73%
1,580,213
110/04
262,801
-8.96%
1,184,090
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
